within Pharmacolibrary.Drugs.N_NervousSystem.N02C_AntimigrainePreparations.N02CC07_Frovatriptan;

model Frovatriptan
  extends Pharmacolibrary.Drugs.ATC.N.N02CC07;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N02CC07</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Frovatriptan is a selective serotonin (5-HT1B/1D) receptor agonist in the triptan class, used for the acute treatment of migraine attacks with or without aura in adults. It is approved for use in several countries for migraine relief.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers (both sexes, age 18-65), after single oral dose administration.</p><h4>References</h4><ol><li><p>Buchan, P, et al., &amp; Ward, C (2002). Clinical pharmacokinetics of frovatriptan. <i>Headache</i> 42 Suppl 2 S54–S62. DOI:<a href=&quot;https://doi.org/10.1046/j.1526-4610.42.s2.3.x&quot;>10.1046/j.1526-4610.42.s2.3.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12028321/&quot;>https://pubmed.ncbi.nlm.nih.gov/12028321</a></p></li><li><p>Sanford, M (2012). Frovatriptan: a review of its use in the acute treatment of migraine. <i>CNS drugs</i> 26(9) 791–811. DOI:<a href=&quot;https://doi.org/10.2165/11209380-000000000-00000&quot;>10.2165/11209380-000000000-00000</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22900951/&quot;>https://pubmed.ncbi.nlm.nih.gov/22900951</a></p></li><li><p>Guidotti, M, &amp; Ravasio, R (2009). Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting. <i>Clinical drug investigation</i> 29(11) 693–702. DOI:<a href=&quot;https://doi.org/10.2165/11315330-000000000-00000&quot;>10.2165/11315330-000000000-00000</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19813772/&quot;>https://pubmed.ncbi.nlm.nih.gov/19813772</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Frovatriptan;
